APA

Trenschel R., Ditschkowski M., Elmaagacli A. H., Koldehoff M., Ottinger H., Steckel N., Hlinka M., Peceny R., Rath P., Dermoumi H. & Beelen D. W. (20050707). Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. : Bone marrow transplantation.

Chicago

Trenschel R, Ditschkowski M, Elmaagacli A H, Koldehoff M, Ottinger H, Steckel N, Hlinka M, Peceny R, Rath P-M, Dermoumi H and Beelen D W. 20050707. Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. : Bone marrow transplantation.

Harvard

Trenschel R., Ditschkowski M., Elmaagacli A. H., Koldehoff M., Ottinger H., Steckel N., Hlinka M., Peceny R., Rath P., Dermoumi H. and Beelen D. W. (20050707). Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. : Bone marrow transplantation.

MLA

Trenschel R, Ditschkowski M, Elmaagacli A H, Koldehoff M, Ottinger H, Steckel N, Hlinka M, Peceny R, Rath P-M, Dermoumi H and Beelen D W. Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. : Bone marrow transplantation. 20050707.